The Terrible—and Amazing—Side Effects of Weight Loss Drugs
PEOPLE TAKING GLP-1S have a reduced risk of heart attacks, strokes, and death from cardiovascular disease, according to a ...
Lexaria's Human GLP-1 Study #5 Receives Independent Review Board Approval
Approved for use by diabetics to control blood sugar, liraglutide has also evidenced an ability to slow cognitive decline in a Phase 2b clinical trial, and reduce shrinkage of those areas of the brain ...
Lexaria Bioscience Corp.: Lexaria's Human GLP-1 Study #5 Receives Independent Review Board Approval
Positive results in a recent animal study strongly supports first-ever human investigation for DehydraTECH-liraglutide in an oral capsule format KELOWNA, BC / ACCESSWIRE / January 15, 2025 / Lexaria B ...
Lexaria’s human GLP-1 study 5 receives IRB approval
Lexaria Bioscience (LEXX) it has received the necessary independent ethics board approval required for its contract research organization to ...
Irish Independent on MSN4d
Patients taking weight-loss jabs at clinic had ‘significant reduction’ in alcohol intake, study shows
Heavy drinkers who were ­taking weight-loss jabs in a Dublin clinic significantly reduced their ­alcohol intake down from 12 to four pints a week, according to a new study. The research was carried ...
TCTMD6d
Variety of GLP-1 Drugs Help People Without Diabetes Lose Weight: Review
With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.